Aspirin, also known as acetylsalicylic acid, is one of the most widely used medications globally, known for its
pain-relieving, anti-inflammatory, and antipyretic properties. Its mechanism of action has intrigued scientists and medical professionals for decades, leading to a comprehensive understanding of how this common drug works at a molecular level.
The primary mechanism of action of aspirin involves the inhibition of
cyclooxygenase (COX) enzymes. There are two main types of COX enzymes in the human body:
COX-1 and
COX-2. These enzymes play a crucial role in the synthesis of prostaglandins and thromboxanes, which are lipid compounds that have various functions, including mediating
inflammation, pain,
fever, and
blood clot formation.
Aspirin exerts its effects by irreversibly acetylating a serine residue in the active site of the COX enzymes, leading to their inhibition. By blocking COX-1 and COX-2, aspirin prevents the conversion of arachidonic acid to prostaglandin H2 (PGH2), a precursor of other prostaglandins and thromboxanes. This inhibition results in several therapeutic effects:
1. Anti-inflammatory: Prostaglandins are mediators of inflammation, and their reduced synthesis leads to decreased inflammation and swelling at sites of injury or
infection.
2. Analgesic (Pain Relief): Prostaglandins also sensitize nerve endings to pain. By reducing prostaglandin levels, aspirin diminishes the sensation of pain.
3. Antipyretic (Fever Reduction): Prostaglandins in the hypothalamus are involved in the regulation of body temperature. Aspirin lowers fever by inhibiting these prostaglandins.
4. Antiplatelet: Thromboxane A2, produced by COX-1 in platelets, plays a key role in platelet aggregation and blood clot formation. By inhibiting COX-1, aspirin reduces thromboxane A2 production, thereby inhibiting platelet aggregation and serving as a blood thinner.
The dual inhibition of COX-1 and COX-2 by aspirin is essential for its effectiveness but also contributes to its side effect profile. Inhibition of COX-1, which is constitutively expressed in most tissues, can lead to gastrointestinal issues such as
ulcers and
bleeding, as COX-1 is involved in protecting the gastric mucosa. On the other hand, selective inhibition of COX-2, which is induced during inflammation, is mainly responsible for the anti-inflammatory and analgesic effects of aspirin.
In addition to its well-known uses, aspirin has been studied for its potential benefits in preventing
cardiovascular diseases and certain
cancers. Its antiplatelet effect makes it a valuable medication for preventing
heart attacks and
strokes in individuals at high risk. Ongoing research is also investigating aspirin's role in reducing the risk of
colorectal cancer and other malignancies, although the exact mechanisms are still being explored.
In summary, the mechanism of action of aspirin involves the irreversible inhibition of COX enzymes, leading to reduced synthesis of prostaglandins and thromboxanes. This results in its anti-inflammatory, analgesic, antipyretic, and antiplatelet effects. While highly effective, the inhibition of COX-1 is also responsible for some of the adverse effects associated with aspirin use. Understanding this mechanism helps healthcare providers effectively utilize aspirin's benefits while managing its potential risks.
How to obtain the latest development progress of all drugs?
In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!


